Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2003

01-06-2003

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study

Authors: Jurgen M. J. Piek, Bas Torrenga, Brenda Hermsen, René H. M. Verheijen, Ronald P. Zweemer, Johan J. P. Gille, Peter Kenemans, Paul J. van Diest, Fred H. Menko

Published in: Familial Cancer | Issue 2/2003

Login to get access
Metadata
Title
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study
Authors
Jurgen M. J. Piek
Bas Torrenga
Brenda Hermsen
René H. M. Verheijen
Ronald P. Zweemer
Johan J. P. Gille
Peter Kenemans
Paul J. van Diest
Fred H. Menko
Publication date
01-06-2003
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1023/A:1025700807451

Other articles of this Issue 2/2003

Familial Cancer 2/2003 Go to the issue

Abstract List

Abstracts presented at the Spring Conference 2003 of the Cancer Genetics Group, 12–13 May 2003, Southampton, UK

OriginalPaper

Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma

Letter to the Editor

The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?

OriginalPaper

Family history of colorectal cancer in a Sweden county

OriginalPaper

Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases

Letter to the Editor

Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits